Association between HLA-DRB1* polymorphisms and hepatitis B infection in a Brazilian population;Associação entre polimorfismos HLA-DRB1* e infecção por hepatite B em uma população brasileira

Revista da Associacao Medica Brasileira

Volumn 58, Issue 5, 2012, Pages 537-542

  Corrêa, Bruno de Melo ^a   Lopes, Edmundo Pessoa de Almeida ^a   de Albuquerque, Maria de Fátima Pessoa Militão ^b   Dourado, Lúcia ^c  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Hemocentro de Pernambuco   (Brazil)

Author keywords

Hepatitis; HLA and HBV infection; HLA antigens; Major histocompatibility complex

Indexed keywords

EID: 84875505807     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0104-42302012000500009     Document Type: Article

References (20)

1. Powis SH, Geraghty DE. What is the MHC? Immunol Today. 1995;16:466-8.
2. Riley E, Olerup O. HLA polymorphisms and evolution. Immunol Today. 1992;13:333-5.
3. Clayton J, Gee H. Major histocompatibility complex: the evolutionary angle. Nature. 1993;365:111-2.
4. Parham P. HLA, anthropology, and transplantation. Transpl Proc. 1993;25:159-61.
5. Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol. 2007;13:1770-87.
6. Xingku L, Wei L, Hongyan W, Xi J, Shaohong F, Yuguang S, Zhen L, Shuyun Z, Shufen Y. The influence of HLA alleles and HBV subgenotypes on the outcomes of HBV infections in Northeast China. Virus Res. 2012;163:328-3.
7. Klein J, Sato A. The HLA system: first of two parts. N Engl J Med. 2000;343:702-9.
8. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunology 1987;53:1-11.
9. Cotrina M, Buti M, Jardi R, Campins M, Esteban R, Guardia J. Study of HLA-II antigens in chronic hepatitis C and B and in acute hepatitis B. Gastroenterol Hepatol. 1997;20:115-8.
10. Visentainer JEL, Sell AM, Tsuneto LT, et al. Metodologia de genotipagem HLA SSO-Luminex no Laboratório de Imunogenética da Universidade Estadual de Maringá. Rev Bras Hematol Hemoter. 2005;1:61-5.
11. Wang JS, Zhu QR. Interruption of the transmission of hepatitis B virus from mother to babies. Zhonghua Gan Zang Bing Za Zhi. 2002;10:308-10.
12. Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol. 2003;77:12083-7.
13. Thursz MR. Host genetic factors influencing the outcome of hepatitis. J Viral Hepat. 1997;4:215-20.
14. Diepolder HM, Jung MC, Keller E, Schraut W, Gerlach JT, Grüner N, et al. A vigorous virus-specific CD4+ T cell response may contribute to the association of HLADR13 with viral clearance in hepatitis B. Clin Exp Immunol. 1998;113:244-51.
15. Meng XQ, Chen HG, Ma YL, Liu KZ. Influence of HLA class II molecules on the outcome of hepatitis B virus infection in population of Zhejiang Province in China. Hepatobiliary Pancreat Dis Int. 2003;2:230-3.
16. Ahn SH, Han KH, Park JY, Lee CK, Kang SW, Chon CY, et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology. 2000;31:1371-3.
17. Jiang YG, Wang YM, Liu TH, Lee CK, Kang SW, Chon CY, et al. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B. World J Gastroenterol. 2003;9:2221-5.
18. Han YN, Yang JL, Zheng SG, Tang Q, Zhu W. Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients. World J Gastroenterol. 2005;11:5721-4.
19. Xu Y, Yu J, Zhong Y, Song HB, Lui HH, Jia LL, et al. Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus. Int J Biol Sci. 2008;4:111-5.
20. Wu YF, Wang LY, Lee TD, Lin HH, Hu CT, Cheng M, et al. HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan. J Med Virol. 2004;72:17-25.